Background illustration for clinical trials search

Paid Clinical Trials Naperville

Discover 2,409 paid clinical trials in Naperville, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Childhood Cancer Survivor Study

for
Cancer
Location: Chicago IL, Indianapolis IN, Ann Arbor MI, St Louis MO,
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0+

Code: NCT01120353

Recruiting

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

for
Non-small Cell Lung Cancer, Colorectal Carcinoma,
Location: Chicago IL, Milwaukee WI, St Louis MO, Westwood KS,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06218914

Phase 1, Recruiting

A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.

for
Advanced Solid Tumors Cancer, MSI-H Cancer
Location: Chicago IL, Maumee OH, Louisville KY, Toronto,
Sponsor: Nimbus Wadjet, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06898450

Phase 1, Phase 2, Recruiting

Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata

for
Alopecia Areata
Location: Chicago IL, Indianapolis IN, Troy MI, Auburn Hills MI,
Sponsor: Sun Pharmaceutical Industries, Inc.

Sex: All

Age: 12 - 17

Code: NCT07133308

Phase 3, Recruiting

Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis

for
Primary Biliary Cholangitis
Location: Chicago IL, Milwaukee WI, Iowa City IA, Detroit MI,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT06051617

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Volume Support/Assist Control Mode Ventilation and Diaphragmatic Atrophy

for
Mechanical Ventilation Complication
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT03901924

Recruiting

Prophylactic Minimally Invasive Surfactant Evaluation

for
Respiratory Distress Syndrome, Newborn, Premature Birth
Location: Evanston IL
Sponsor: Endeavor Health

Sex: All

Age: 0

Code: NCT06007547

Recruiting

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

for
Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC),
Location: Glenview IL, Gurnee IL, Milwaukee WI, Ypsilanti MI,
Sponsor: Mirador Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07113522

Phase 2, Recruiting

Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation

for
Longevity, GLP-1, Geroscience, Aging
Location: Chicago IL
Sponsor: AgelessRx

Sex: All

Age: 40 - 70+

Code: NCT07092618

Phase 2, Phase 3, Recruiting

A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)

for
Acute Myeloid Leukemia
Location: Chicago IL, Grand Rapids MI, Columbus OH, Buffalo NY,
Sponsor: Debiopharm International SA

Sex: All

Age: 18+

Code: NCT06969430

Phase 1, Phase 2, Recruiting

Olaparib in Patients With HRD Malignant Mesothelioma

for
Mesothelioma, Homologous Recombination Deficiency
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT04515836

Phase 2, Recruiting

A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

for
High-risk Myelodysplastic Syndrome,
Location: Chicago IL, St Louis MO, Nashville TN, Philadelphia PA,
Sponsor: Crossbow Therapeutics, Inc.

Sex: All

Age: 12+

Code: NCT06994676

Phase 1, Recruiting

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

for
Advanced or Metastatic Solid Tumors, Breast Cancer,
Location: Chicago IL, Rochester MN, Columbus OH, Fairfax VA,
Sponsor: 858 Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06395519

Phase 1, Phase 2, Recruiting

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

for
Metastatic Uveal Melanoma
Location: Chicago IL, Madison WI, Iowa City IA, Rochester MN,
Sponsor: Replimune Inc.

Sex: All

Age: 0+

Code: NCT06581406

Phase 2, Phase 3, Recruiting

Brentuximab Vedotin and Nivolumab for the Treatment of Patients With Relapsed/Refractory Classical Hodgkin Lymphoma

for
Relapsed Classic Hodgkin Lymphoma
Location: Chicago IL, Nashville TN, Hackensack NJ, Boston MA,
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT04561206

Phase 2, Recruiting

Menthol, Inflammation, and Nicotine Transition Study

for
Cigarette Smoking, Inflammatory Response
Location: North Chicago IL
Sponsor: Rosalind Franklin University of Medicine and Science

Sex: All

Age: 21 - 70+

Code: NCT06232447

Recruiting

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

for
Prostate Cancer,
Location: Chicago IL, Milwaukee WI, Madison WI, St Louis MO,
Sponsor: Janux Therapeutics

Sex: Male

Age: 18 - 70+

Code: NCT05519449

Phase 1, Recruiting

Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors

for
Solid Tumor, Adult, Mesothelioma, NSCLC
Location: Chicago IL, Minneapolis MN, Arlington VA, New York NY,
Sponsor: Vivace Therapeutics, Inc

Sex: All

Age: 18+

Code: NCT04665206

Phase 1, Phase 2, Recruiting

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

for
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia,
Location: Chicago IL, Iowa City IA, St Louis MO, Columbus OH,
Sponsor: Syndax Pharmaceuticals

Sex: All

Age: 0+

Code: NCT04065399

Phase 1, Phase 2, Recruiting

Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial

for
Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8,
Location: Zion IL, Newnan GA, Goodyear AZ, Upland CA, Corona CA,
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT07288034

Phase 2, Recruiting